Electrocardiograms showed sinus rhythm, right axis deviation, signs of right ventricular hypertrophy and strain, and accentuated and peaked P-waves (Fig. 4,  overleaf) .
Intracardiac pressure-recordings in September, 1968, revealed a marked pulmonary hypertension of precapillary type (Table I) . 
Pathological findings
The heart was moderately enlarged (390 g.) with a marked right ventricular hypertrophy (9 mm.) Fig. 5, overleaf) . The coronary arteries, myocardium, and heart valves were unremarkable. In the pulmonary artery and its main branches there was a marked atheromatosis (Fig. 6 , overleaf), while the pulmonary parenchyma was mainly normal. There was ascites (500 ml.), and the liver (1,355 g.) and the spleen had a picture of marked chronic congestion. The microscopical examination showed a typical picture of scleroderma in the dermal preparations (Fig. 7) . The calcifications of Thibi&ge-Weissenbach type had the characteristic picture. There were no signs of fibrosis in the lungs, but marked thickening of the walls of the medium-large and small pulmonary arteries and arterioles caused by medial muscular and intimal hyperplasia with very significant reduction of the lumina of the vessels (Figs 8 and 9 necropsied. They were specially examined in regard to pulmonary fibrosis, arteriosclerosis of the pulmonary vessels and heart size. One case had to be omitted because of a diffuse cancer in the lungs. The findings in the remaining four men and five women are presented in Table II , (opposite), and the extent of pulmonary arteriosclerosis and pulmonary fibrosis are further summarized in Table III (opposite) .
Figures 8 to 15 (overleaf) show examples of different degrees and combinations of these lesions. There appeared to be no strong tendency to a correlation between them. However, all the male subjects had moderate or marked fibrosis, while the women were mainly represented in the lower part of the pulmonary fibrosis scale.
Review of the literature A. MORBID ANATOMICAL INVESTIGATIONS
That pulmonary fibrosis can be associated with right cardiac hypertrophy in systemic sclerosis was early understood (Sackner, 1962; Weaver, Divertie, and Titus, 1967) . The significance of both pulmonary vascular and parenchymatous changes in this connection was originally noted by Matsui (1924) , who also recognized that pleural effusions or adhesions, restriction of the thorax by skin changes, and impairment of the function of the respiratory muscles might disturb the pulmonary circulation. Perivascular inflammatory cell reaction (Masugi and Ya-Shu, 1938; Fischer and Hansen, 1956 ) and thromboembolism (Masugi and Ya-Shu, 1938; and Naeye, 1963) in the pulmonary arterial bed, pulmonary arteritis with fibrinoid necrosis and inflammation (Montgomery, Stirling, and Hamer, 1964; Weaver, Divertie, and Titus, 1968) , and changes in the pulmonary veins (Naeye, 1963) have been encountered in cases of systemic sclerosis from time to time, but seem to be of little importance. Several investigations of sizeable necropsy series (Naeye, 1963; Sackner, Heinz, and Steinberg, 1966 (1967) . In the recent and independent manifestations of the disorder. investigation of Sackner, Akgun, Kimbel, and Lewis They are both often associated with hypertrophy of (1964) , it was demonstrated that pulmonary hyperthe right ventricle; this association is perhaps more tension and lung function values indicative of significant within pulmonary arterial lesions (Sack-restrictive and obstructive lung disease might ner and others, 1966). These findings are reflected co-exist in systemic sclerosis, but are not infrealso in our series (Tables II and III Opie (1955) . We have found in the literature eleven clinically described cases of systemic sclerosis with pulmonary hypertension verified by heart catheterization: Table IV, overleaf (Spain and Thomas, 1950; Austrian, McClement, Renzetti, Donald, Riley, and Cournand, 1951; Foss, 1954; Ellman and Cudkowicz, 1954; Bauer, 1955; Opie, 1955; Fischer and Hansen, 1956; Castleman and Kibbee, 1960; Soulie, Acar, Joly, Carlotti, Bernard, Azhrad, and Casillon du Perron, 1961; Pace, Decker, and Martin, 1963; Tourniaire, Blum, Tarlulier, and Deyrieux, 1964) .
As with the morbid anatomical and physiological studies, three groups may be discerned:
(1) Predominantly lung fibrosis; (2) Both pulmonary parenchymatous and vascular lesions; The pulmonary hypertension always appears to be of 'precapillary' type, and there are no obvious differences in age, sex, or duration of the disease between the groups.
Discussion
The lung fibrosis of systemic sclerosis may induce pulmonary hypertension by replacement and mechanical compression of the pulmonary vascular bed (Weaver and others, 1967) and by periadventitial fibrosis and hyalinization. Fibrosis may also cause hypoxia through thickening of the alveolar septa, limitation of the ventilatory movements, and possibly by arterio-venous shunting in the lungs (Weaver and others, 1967) . Hypoxia may itself contribute to pulmonary hypertension (Opie, 1955; Weaver and others, 1967) . Short-term hypoxia raises the pulmonary artery pressure in normal subjects (Von Euler and Liljestrand, 1946; Motley, Cournand, Werk6, Himmelstein, and Dresdale, 1947; Bergofsky and Holtzman, 1967; Bergofsky, Haas, and Porcelli, 1968) , and protracted hypoxia may be associated with pulmonary hypertension and hyperplastic changes in the pulmonary arterioles and small muscular arteries (Hasleton, Heath, and Brewer, 1968; Addington, Pfeffer, and Gaensler, 1969) .
Hypercapnia (Bergofsky and others, 1968) and acidosis (Liljestrand, 1958; Harvey, Enson, Betti, Lewis, Rochester, and Ferrer, 1967) are other possible mechanisms, but seem to be insignificant in systemic sclerosis, since there is instead in the majority of cases a mild respiratory alkalosis because of hyperventilation (Weaver and others, 1967) .
Primary hyperplastic changes in the pulmonary arteries in systemic sclerosis have been interpreted as manifestations of the common widespread vasomotor disturbances (Sackner, 1962; Sackner and others, 1964) . The pulmonary arteries are influenced by the sympathetic nervous system, "overactivity" of which is also inferred in Raynaud's phenomenon (Rogge, Mishkin, and Genovese, 1966) . A protracted The term 'pulmonary arteriosclerosis' also includes hyperplastic changes in smaller pulmonary arterial ramifications (hyperplasia of intima and media, and arteriolosclerosis). Cases B, C, D, F, and K were investigated by chest x-ray only, and no conclusions could be drawn. In Case I the description was insufficiently detailed.
Pulmonary hypertension in systemic sckrosis 399 spasm in the smaller pulmonary arteries may induce irreversible lumen-reducing changes of medial hypertrophy and intimal proliferation in their walls (Short, 1957; Celoria, Friedell, and Sommers, 1960; Downing, Bidone, Brandt, and Liebow, 1963; Boiteau and Libanoff, 1963; Hasleton and others, 1968) . However, the major effects in the lesser ariculation of (short-term) sympathetic nerve stimulation seem to be exerted on the larger pulmonary rcteries rather than on the smaller, and cause little change in pulmonary vascular resistance (Ingram, Szidon, Skalak, and Fishman, 1968) . Another possibility is that the sympathetic "overactivity" in the smaller pulmonary arteries reflects a local rather than a central disturbance. At least in capillary basal membranes, swelling and other pathological changes are a regular feature of systemic sclerosis (Norton, Hurd, Lewes, and Zift, 1968; Norton and Nardo, 1970) . It seems possible that pulmonary arterial vasoconstriction may be secondary to a local sclerodermatous involvement which disturbs, for instance by inflammatory or degenerative action, the function of the active electrolyte transport system of the cell membrane in the pulmonary arterial smooth muscle, so that the resting negative intracellular potential moves closer to zero and to the threshold for the production of action potentials and active contraction. Recent data suggest that, in such a situation, a vasoconstriction will occur in the pulmonary vasculature (Bergofsky and Holtzman, 1967) .
Pulmonary hypertension has exceptionally been reported in collagenoses other than systemic sclerosis (Ellman and Cudlowicz, 1954; Caldwell and Aitchison, 1956; Sullivan and Miller, 1962; Pace and others, 1963; Onodera and Hill, 1965) , but in systemic sclerosis a disturbance of the pulmonary circulation appears to be a regular rather than an exceptional development in the long perspective of the disorder. Our case may still be a rare extreme in the variability of possible combinations and degrees of different pulmonary lesions in systemic sclerosis. By the dominant arterial involvement it resembles reported cases of 'Primary pulmonary hypertension and Raynaud's phenomenon', most of them females, and some actually representing typical systemic sclerosis (Winters, Joseph, and Learner, 1964) . Even cases without skin changes may fall within the systemic sclerosis symptom complex (Sackner and others, 1964) . This would seem to be a clue to the aetiology of 'primary' pulmonary hypertension, but primary pulmonary hypertension is not a uniform disease. For instance, familial occurrence (which in itself does not rule out a collagenous nature (Rogge and others, 1966; and Burge, Perry, and Stickler, 1969) ) has been described (see Boiteau and Libanoff, 1963; Rogge and others, 1966) , and such cases usually differ in clinical and morbid anatomical respects from 'primary pulmonary hypertension and Reynaud's phenomenon'. Summary A case is reported of a 57-year-old woman with systemic sclerosis, who developed a severe pulmonary hypertension and rapidly progressive right heart failure attributable to hyperplastic changes in the smaller pulmonary arteries and arterioles. A retrospective investigation of pulmonary lesions in a necropsy series of cases of systemic sclerosis showed that both lung fibrosis and hyperplastic changes in the pulmonary arteries are common in the disorder, that they may be independant of each other, and that both may be associated with right cardiac hypertrophy. This is in accordance with the findings in earlier morbid anatomical, physiological, and clinical studies concerning cor pulmonale and pulmonary hypertension in systemic sclerosis, which are reviewed. Some possible mechanisms of pulmonary hypertension in systemic sclerosis and the relationship of the reported case to various types of 'primary pulmonary hypertension' are discussed.
